杏林製薬株式会社: management transactions · Japan · EDINET (Japan FSA)

Browse the full insider trade history of 杏林製薬株式会社, a listed equity based in Japan. Shares are listed on JP JP, under the authority of EDINET (Japan FSA). Operating in the Healthcare sector, 杏林製薬株式会社 has published 1 public disclosures. Market capitalisation: €82.2bn. The latest transaction was reported on 21 June 2023 — Holding update. Among the most active insiders: Kopernik Global Investers, LLC. The full history is openly available.